Condition
Hepatobiliary Malignancy clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hepatobiliary Malignancy clinical trials that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Fluoxetine added to immunotherapy for advanced liver and gallbladder cancer with depression or anxiety
This trial will test whether adding the antidepressant fluoxetine to standard PD-1/PD-L1 immunotherapy helps people with advanced liver or gallbladder cancers who also have depression or anxiety.
-
Using 68Ga-grazytracer PET to monitor immunotherapy responses in liver cancer
This study is testing if a special type of imaging can help doctors see how well immunotherapy is working for people with advanced liver cancer after a few treatment cycles.
Related topics
Quick answers
How many Hepatobiliary Malignancy clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.